Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor (NCT03158688)
Saad Z. Usmani,Hang Quach,Maria-Victoria Mateos,Ola Landgren,Xavier Leleu,David S. Siegel,Katja Weisel,Hui Yang,Zandra Klippel,Anita Zahlten-Kumeli,Meletios A. Dimopoulos
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
无极微光
OsamaKareem
MchemG
靤君
学术文献互助
Peeta
YifanWang
仰望喀纳斯的星空
贪玩的秋柔
Singularity
zp560
sanvva
披着羊皮的狼
大力的灵雁
Hayat
缓慢怜菡
Rita
morena
laber
皖公网安备34019202002308
